Asciminib Roll-over Study
Novartis
Novartis
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
University of Michigan Rogel Cancer Center
MPN Research Foundation
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Incyte Corporation
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ascentage Pharma Group Inc.
UNC Lineberger Comprehensive Cancer Center
Children's Oncology Group
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Astex Pharmaceuticals, Inc.
City of Hope Medical Center
Columbia University
Takeda
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Nebraska
M.D. Anderson Cancer Center
University of Nebraska
University of Nebraska
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Rush University Medical Center
Memorial Sloan Kettering Cancer Center
Xencor, Inc.
Northwestern University
Incyte Corporation
Roswell Park Cancer Institute
Novartis
Novartis
Takeda
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center